Events & Presentations

Investors

Events & Presentations

Upcoming Events
Date Event Details Remind Me
Dec 14, 2016
4:30 PM ET
Arrowhead Fiscal 2016 Year End Results
Email

Arrowhead Fiscal 2016 Year End Results

Remind Me

Please sign up for Email alerts.


Archived Events
Date Event Details
Nov 30, 2016
8:30 AM ET
The 28th Annual Piper Jaffray Healthcare Conference
Location: New York

November 30, 8:30 a.m. EST – Christopher Anzalone, Ph.D., Arrowhead president and CEO will deliver a corporate overview in a fireside chat with Ted Tenthoff, senior research analyst, Piper Jaffray.

Presentation Canceled

Nov 29, 2016
4:30 PM ET
Clinical Update Call
Nov 14, 2016
10:00 AM CT
American Heart Association's Scientific Sessions 2016
Location: New Orleans

November 14, 10:40 a.m. CST – Stacey Melquist, Ph.D., Arrowhead senior scientist will deliver an oral presentation titled, “Targeting factor XII (F12) with a novel RNAi delivery platform as a prophylactic treatment for thromboembolism”

November 14, 2:00 p.m. CST – Stacey Melquist, Ph.D., Arrowhead senior scientist will deliver an oral presentation titled, “Targeting apolipoprotein(a) with a novel RNAi delivery platform as a prophylactic treatment to reduce risk of cardiovascular events in individuals with elevated lipoprotein (a)”

Nov 13, 2016
The Liver Meeting® 2016, the Annual Meeting of the American Association for the Study of Liver Disease
Location: Boston

RNA interference therapeutic ARC-AAT prevents production of Z-alpha1 antitrypsin polymers and reverses liver disease phenotype in PiZ mouse model

  • Publication Number: 124
  • Session: Parallel 19: Pediatric and Metabolic Liver Diseases: Basic and Translational
  • Session Date and Time: November 13, 2016 from 4:45 PM to 6:15 PM
  • Authors: Christine Wooddell, et al.

RNA interference (RNAi) with ARC-AAT provides deep and prolonged knockdown of alpha-1 antitrypsin levels in healthy volunteers

  • Publication Number: LB-24
  • Session: Late-Breaking Poster Session
  • Session Date and Time: November 13, 2016 from 8:00 AM to 5:30 PM

Authors: Alice Turner, et al.

Nov 7, 2016
11:30 AM MT
The 25th Annual Credit Suisse Healthcare Conference
Location: Scottsdale, AZ

November 7, 11:30 a.m. MST – Christopher Anzalone, Ph.D., Arrowhead president and CEO will deliver a corporate presentation.

Sep 29, 2016
6:00 AM PT
Arrowhead/Amgen Collaboration Call
Sep 23, 2016
7:30 PM ET
2016 International HBV Meeting
Location: Seoul, Korea

September 24, 8:30 a.m. KST – Zhao Xu, Ph.D., Arrowhead senior scientist will deliver an oral presentation titled, “Functional HBsAg-encoding HBV fusion transcripts are produced from integrated HBV DNA in chronically infected chimpanzees - evidence from single molecule, real time (SMRT) sequencing”

Sep 14, 2016
4:30 PM ET
7th Non-Coding RNA & RNAi Therapeutics Conference
Location: Boston

September 14, 4:30 p.m. EDT – Erik Bush, Ph.D., Arrowhead director of extrahepatic targeting will deliver an oral presentation titled, “Targeted delivery strategies using Dynamic PolyconjugateTM (DPCTM) technology”

Sep 9, 2016
10:00 AM ET
The 23rd Annual NewsMakers in the Biotech Industry
Location: New York

September 9, 10:00 a.m. EDT – Christopher Anzalone, Ph.D., Arrowhead president and CEO will deliver a corporate presentation

Aug 9, 2016
4:30 PM ET
Arrowhead Fiscal 2016 Third Quarter Results
Jul 13, 2016
10:45 AM ET
Cantor Fitzgerald 2nd Annual Healthcare Conference
Location: New York
Jun 10, 2016
10:30 AM ET
Jefferies 2016 Healthcare Conference
Location: New York
May 28–29, 2016
5th Asian Conference on Hepatitis and AIDS (ACHA)

May 29, 4:50 p.m. CST (China Standard Tim) – Bruce Given, M.D., Arrowhead chief operating officer will deliver an oral presentation titled, “RNAi therapeutics for chronic HBV - Animal models”

May 10, 2016
4:30 PM ET
Arrowhead Fiscal 2016 Second Quarter Results
May 9–12, 2016
IBC's 18th Annual TIDES: Oligonucleotide and Peptide Therapeutics
Location: Long Beach, California
May 9, 1:30 p.m. PDT – David Rozema, Ph.D., Arrowhead vice president of chemistry will deliver an oral presentation titled, “Protease-sensitive endosomal escape for delivery of siRNA in vivo”
 
May 9, 1:30 p.m. PDT – Qingguo Tian, Ph.D., Arrowhead bioanalytical project manager will deliver an oral presentation titled, “Sensitive and specific quantification of oligonucleotides in biological matrices using hybridization based LC-fluorescence assays”
 
May 5–7, 2016
Arteriosclerosis, Thrombosis and Vascular Biology | Peripheral Vascular Disease (ATVB|PVD) 2016 Scientific Sessions
Location: Nashville

May 6, 11:00 a.m. CDT – Stacey Melquist, Ph.D., Arrowhead senior scientist, and coauthors, will deliver a poster presentation titled, “Lipoprotein(a) targeting with RNAi delivery platforms in transgenic mice and cynomolgus monkeys” (Presentation Number 428)

Apr 16–20, 2016
American Association for Cancer Research Annual Meeting 2016 (AACR16)
Location: New Orleans

April 18, 1:00 p.m. CDT – So Wong, Ph.D., Arrowhead director of oncology, and coauthors, will deliver a poster presentation titled, “Novel HIF-2α targeted RNAi therapeutic for renal cell carcinoma” (abstract 2064)

Apr 13–17, 2016
The International Liver Congress™ 2016 (ILC 2016) – The Annual Meeting of the European Association for the Study of the Liver
Location: Barcelona, Spain

April 14, 8:00 a.m. CEST – Zhao Xu, Ph.D., Arrowhead senior scientist, and coauthors, will deliver a poster presentation titled, “Treatment of chronically HBV-infected chimpanzees with RNA interference therapeutic ARC-520 led to potent reduction of viral mRNA, DNA and proteins without observed drug resistance” (abstract THU-213)

April 14, 8:00 a.m. CEST – Man-Fung Yuen, M.D., Ph.D., chair of gastroenterology and hepatology, The University of Hong Kong, and deputy chief of service, Queen Mary Hospital department of medicine, Hong Kong, and coauthors, will deliver a poster presentation titled, “Differential reductions in viral antigens expressed from cccDNA vs integrated DNA in treatment naïve HBeAg positive and negative patients with chronic HBV after RNA interference therapy with ARC-520” (abstract THU-193)

April 15, 8:00 a.m. CEST – Renae Walsh, Ph.D., senior scientist, Victorian Infectious Diseases Reference Laboratory, and coauthors, will deliver a poster presentation titled, “Predicting HBsAg clearance responses during ARC-520 RNA interference (RNAi) therapy based on HBsAg epitope profile analysis” (abstract FRI-144)

Mar 15–17, 2016
Barclays Global Healthcare Conference
Location: Miami
March 17, 10:15 a.m. EST – Chris Anzalone, Ph.D., Arrowhead president and chief executive officer, will present a company overview
Mar 7–9, 2016
Cowen and Company 36th Annual Healthcare Conference
Location: Boston
March 7, 4:00 p.m. EST – Chris Anzalone, Ph.D., Arrowhead president and chief executive officer, will present a company overview
Mar 4–7, 2016
2016 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
Location: Los Angeles
March 7, 9:45 a.m. PST – Stacey Melquist, Ph.D., Arrowhead senior scientist, and coauthors, will deliver a poster presentation titled, “Targeting Factor 12 (F12) with a Novel RNAi Delivery Platform As a Prophylactic Treatment for Hereditary Angioedema (HAE)”
Feb 23–24, 2016
2016 RBC Capital Markets' Global Healthcare Conference
Speaker: Chris Anzalone, Ph.D., Arrowhead president and chief executive officer, and David Lewis, Ph.D., Arrowhead chief scientific officer
Location: New York

February 23, 9:30 a.m. EST – Chris Anzalone, Ph.D., Arrowhead president and chief executive officer, and David Lewis, Ph.D., Arrowhead chief scientific officer, will participate in a fireside chat with Michael Yee, managing director – biotechnology equity research, RBC Capital Markets

Feb 20–24, 2016
25th Conference of the Asian Pacific Association for the Study of the Liver
Speaker: Man-Fung Yuen, M.D., Ph.D.
Location: Tokyo

February 22, 1:30 p.m. JST – Man-Fung Yuen, M.D., Ph.D., chair of gastroenterology and hepatology, The University of Hong Kong, and deputy chief of service, Queen Mary Hospital department of medicine, Hong Kong, and coauthors, will deliver an oral presentation titled, “Effective Inhibition of cccDNA Derived mRNA/Viral Antigens and Tolerability with ARC-520

Feb 9, 2016
4:30 PM ET
Arrowhead Fiscal 2016 First Quarter Results
Dec 14, 2015
1:30 PM PT
Arrowhead Fiscal 2015 Year End Results
Dec 6–10, 2015
HEP DART 2015
Location: Wailea, Hawaii

December 8, 6:40 p.m. HST – Bruce Given, M.D., Arrowhead chief operating officer, will deliver an oral presentation titled, “New insights on HBV biology from the ARC-520 development program

December 8, 4:00 - 5:30 p.m. HST – Christine Wooddell, Ph.D., Arrowhead group leader will deliver a poster presentation titled, “Sustained reduction in HBsAg, HBV DNA and HBeAg seroconversion in a chronically HBV-infected chimpanzee treated with nucleoside analog/ARC-520 combination therapy

Dec 1–2, 2015
Piper Jaffray 27th Annual Healthcare Conference
Location: New York

December 2, 3:00 p.m. EST – Chris Anzalone, Ph.D., Arrowhead president and chief executive officer, will present a company overview in a fireside chat with Ted Tenthoff, senior research analyst, Piper Jaffray

Nov 18–19, 2015
Jefferies Autumn 2015 Global Healthcare Conference
Location: London, UK

November 19, 2:40 p.m. GMT – Chris Anzalone, Ph.D., Arrowhead president and chief executive officer, will present a company overview

Nov 17, 2015
8:00 AM PT
The Liver Meeting 2015®, 66th Annual Meeting of the American Association for the Study of Liver Disease (AASLD)

November 17, 8:00 a.m. - 12:00 p.m. PST - Christine Wooddell, Ph.D., group leader will deliver a poster presentation titled, "Monthly dosing of ARC-520 in chronically hepatitis B virus infected chimpanzees produces rapid, deep and durable reductions in circulating viral antigens"

Nov 16, 2015
6:30 PM PT
The Liver Meeting 2015®, 66th Annual Meeting of the American Association for the Study of Liver Disease (AASLD)

November 16, 6:30 p.m. PST - Arrowhead management will host an Analyst and Investor Reception to discuss ARC-520 and key data being presented at the conference

Nov 16, 2015
8:00 AM PT
The Liver Meeting 2015®, 66th Annual Meeting of the American Association for the Study of Liver Disease (AASLD)

November 16, 8:00 a.m. - 5:30 p.m. PST – Man-Fung Yuen, M.D., Ph.D., chair of gastroenterology and hepatology, The University of Hong Kong, and deputy chief of service, Queen Mary Hospital department of medicine, Hong Kong, will deliver a late-breaking poster presentation titled, “ARC-520 produces deep and durable knockdown of viral antigens and DNA in a phase II study in patients with chronic hepatitis B

Nov 15, 2015
3:15 PM PT
The Liver Meeting 2015®, 66th Annual Meeting of the American Association for the Study of Liver Disease (AASLD)
Location: San Francisco

November 15, 3:15 p.m. PST - Christine Wooddell, Ph.D., group leader will deliver an oral presentation titled, "Reductions in cccDNA under NUC and ARC-520 therapy in chimpanzees with chronic hepatitis B virus infection implicate integrated DNA in maintaining circulating HBsAg"

Oct 14, 2015
3:30 PM CET
11th Annual Meeting of the Oligonucleotide Therapeutics Society
Speaker: Bruce Given, M.D., Chief Operating Officer
Location: Netherlands
Oct 7, 2015
5:00 PM CET
2015 International Meeting on Molecular Biology of Hepatitis B
Speaker: Christine Wooddell, Ph.D., Group Leader
Location: Germany
Oct 6, 2015
2:45 PM ET
Partnerships in Drug Delivery
Speaker: David Rozema, Ph.D., Vice President, Chemistry
Location: Boston
Sep 27, 2015
4:45 PM CET
European Cancer Congress 2015
Location: Vienna

Title: HIF-2α targeting with a novel RNAi delivery platform as therapy for renal cell carcinoma (abstract #353)

Sep 24, 2015
11:00 AM ET
2015 Analyst Day
Aug 6, 2015
11:15 AM ET
Jefferies 2015 Hepatitis B Summit
Speaker: Bruce Given, M.D., Chief Operating Officer
Location: Boston
Aug 4, 2015
4:30 PM ET
Arrowhead Fiscal 2015 Third Quarter Financial Results
Jun 3, 2015
10:00 AM ET
Jefferies 2015 Healthcare Conference
Speaker: Christopher Anzalone, Ph.D., President and Chief Executive Officer
May 11, 2015
4:30 PM ET
Arrowhead Fiscal 2015 Second Quarter Financial Results
May 7, 2015
2:50 PM ET
Deutsche Bank 40th Annual Health Care Conference
Location: Boston
May 3–6, 2015
IBC's 17th Annual TIDES Conference
Location: San Diego

May 5, 4:45 p.m. PDT - Christine Wooddell, Ph.D., group leader will deliver an oral presentation titled, "A Hepatocyte-Targeted RNAi Therapeutic for Alpha-1-Antitrypsin Deficiency-Associated Liver Disease"

View Presentation

May 6, 12:15 p.m. PDT - David Lewis, Ph.D., chief scientific officer will deliver an oral presentation titled, "Using DPC Technology in RNAi Therapeutics for Chronic HBV Infection and Factor 12-Mediated Diseases"

View Presentation

= add file to Briefcase